Evidence-based neonatal care

Best Practice and Research: Clinical Obstetrics and Gynaecology

Volumn 19, Issue 1 SPEC. ISS., 2005, Pages 155-166

  Halliday, Henry L ^a  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Evidence based medicine; Neonatal care; Neonate; Neonatology; Randomized controlled trials; Systematic reviews

Indexed keywords

BILIRUBIN; CISAPRIDE; CORTICOSTEROID; DEXAMETHASONE; DOMPERIDONE; DOPAMINE; LUNG SURFACTANT; OXYGEN; PENICILLIN G; RANITIDINE;

ARTIFICIAL VENTILATION; BILIRUBIN BLOOD LEVEL; BLINDNESS; BREAST FEEDING; CEREBRAL PALSY; CHEMOPROPHYLAXIS; CHRONIC LUNG DISEASE; CLINICAL TRIAL; COCHRANE LIBRARY; COST BENEFIT ANALYSIS; DISEASE ASSOCIATION; DRUG SAFETY; EVIDENCE BASED MEDICINE; EXCHANGE BLOOD TRANSFUSION; GASTROESOPHAGEAL REFLUX; HEART ARRHYTHMIA; HEMOLYTIC ANEMIA; HIGH FREQUENCY OSCILLATION; HIGH FREQUENCY VENTILATION; HUMAN; HYPOTENSION; KERNICTERUS; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; NEWBORN CARE; NEWBORN DEATH; NEWBORN INFECTION; NEWBORN INTENSIVE CARE; PHOTOTHERAPY; PNEUMOTHORAX; POSITIVE END EXPIRATORY PRESSURE; POSTNATAL CARE; PRIORITY JOURNAL; RESUSCITATION; REVIEW; RISK REDUCTION; SEPSIS; STREPTOCOCCUS AGALACTIAE; SYSTEMATIC REVIEW; VERY LOW BIRTH WEIGHT;

EID: 14744293895     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpobgyn.2004.10.014     Document Type: Review

References (76)

1. P. Budin The Nursling. The Feeding and Hygiene of Premature and Full-term Infants translated by Maloney WJ 1907 Caxton London
2. M.M. Desmond A review of newborn medicine in America: European and guiding ideology American Journal of Perinatology 8 1991 308-322
3. P.M. Dunn Julius Hess, MD (1876-1955) and the premature infants Archives of Disease in Childhood Fetal and Neonatal Edition 85 2000 F141-F144
4. V.M. Crosse The Premature Baby 1945 J and A Churchill London
5. N.M. Nelson A decimillennium in neonatology Journal of Pediatrics 137 2000 731-735
6. A.J. Schaffer Diseases of the Newborn 1960 WB Saunders Philadelphia
7. M.E. Avery Neonatology Pediatrics 102 supplement 1 1998 270-271
8. W.A. Silverman Retrolental Fibroplasia. A Modern Parable 1980 Grune and Stratton New York
9. H.L. Halliday 11th James Hutchinson Lecture: Evidence-based paediatrics Hong Kong Journal of Paediatrics 5 2000 146-152
10. G.B. Merenstein A.D. Glicken Best evidence-based practices: A historic perspective Neonatal Network 21 2002 3-35
11. J.C. Sinclair Assessing evidence concerning treatment and prevention of diseases of the newborn. In: J.C. Sinclair M.B. Bracken (Eds.) Effective Care of the Newborn Infant 1992 Oxford University Press Oxford 3-12
12. D. Field D. Elbourne The randomized controlled trial Current Paediatrics 3 2003 53-57
13. M.B. Bracken Statistical methods for analysis of effects of treatment in overviews of randomized trials. In: J.C. Sinclair M.B. Bracken (Eds.) Effective Care of the Newborn Infant 1992 Oxford University Press Oxford 13-18
14. J.C. Sinclair M.B. Bracken J.D. Horbar R.F. Soll Introduction to systematic reviews Pediatrics 100 1997 892-895
15. Cochrane Library. http://www.cochrane.org
16. J.C. Sinclair D.E. Haughton M.B. Bracken et al. Cochrane neonatal systematic reviews: A survey of the evidence for neonatal therapies Clinics in Perinatology 30 2003 285-304
17. B. Zhang B. Schmidt Do we measure the right end points? A systematic review of primary outcomes in recent neonatal randomised clinical trials Journal of Pediatrics 138 2001 76-80
18. Halliday HL, Ehrenkranz RA, Doyle LW. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants (Cochrane Review). In The Cochrane Library, Issue 1. Oxford: Update Software; 2003.
19. C.P.F. O'Donnell P.G. Davis C.J. Morley Resuscitation of premature infants: What are we doing wrong and can we do better? Biology of the Neonate 84 2003 76-82
20. M.S. Kramer B. Chalmers E.D. Hodnett et al. Promotion of breastfeeding intervention trial (PROBIT): A randomized trial in the Republic of Belarus Journal of the American Medical Association 285 2001 413-420
21. N. Ambalavanan R.K. Whyte The mismatch between evidence and practice. Common therapies in search of evidence Clinics in Perinatology 30 2003 305-331
22. R.J. Cremer P.W. Perryman D.H. Richards Influence of light on the hyperbilirubinaemia of infants Lancet 1 1958 1094-1097
23. A.K. Brown M.H. Kim P.Y.K. Wu et al. Efficacy of phototherapy in prevention and management of neonatal hyperbilirubinemia Pediatrics 75 1985 393-400
24. P.L. Mollison W. Walker Controlled trials of the treatment of haemolytic disease of the newborn Lancet 1 1952 429-433
25. M.J. Maisels Neonatal jaundice. In: J.C. Sinclair M.B. Bracken (Eds.) Effective Care of the Newborn Infant 1992 Oxford University Press Oxford 507-561
26. Soll RF. Prophylactic natural surfactant extract for preventing mortality and morbidity in preterm infants (Cochrane Review). In The Cochrane Library, Issue 4. Oxford: Update Software; 2003.
27. Soll RF. Prophylactic synthetic surfactant for preventing morbidity and mortality in preterm infants (Cochrane Review). In The Cochrane Library, Issue 4. Oxford: Update Software; 2003.
28. Soll RF. Synthetic surfactant for respiratory distress syndrome in preterm infants (Cochrane Review). In The Cochrane Library, Issue 4. Oxford: Update Software; 2003.
29. H.L. Halliday Respiratory distress syndrome. In: A Greenough A.D. Milner (Eds.) Neonatal Respiratory Disorders 2003 Arnold London 247-271
30. H.L. Halliday Natural vs synthetic surfactants in neonatal respiratory distress syndrome Drugs 51 1996 226-237
31. Soll RF, Blanco F. Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome (Cochrane Review). In The Cochrane Library, Issue 4. Oxford: Update Software; 2003.
32. J. Egberts R. Brand H. Walti et al. Mortality, severe respiratory distress syndrome and chronic lung disease of the newborn are reduced more after prophylactic than after therapeutic administration of the surfactant Curosurf Pediatrics 100 1997 e4
33. Soll RF, Morley CJ. Prophylactic versus selective use of surfactant for preventing morbidity and mortality in preterm infants (Cochrane Review). In The Cochrane Library, Issue 4. Oxford: Update Software; 2003.
34. H.L. Halliday C.P. Speer Strategies for surfactant therapy in established neonatal respiratory distress syndrome. In: B. Robertson H.W. Taeusch (Eds.) Surfactant Therapy for Lung Disease 1995 Marcel Dekker New York 443-459
35. E.E. Farrell R.K. Silver L.V. Kimberlin et al. Impact of antenatal dexamethasone administration on respiratory distress syndrome in surfactant-treated infants American Journal of Obstetrics and Gynecology 161 1989 628-633
36. H.L. Halliday Which interventions for neonatal respiratory failure are effective? Croatian Medical Journal 39 1998 165-170
37. E. Bancalari J.C. Sinclair Mechanical ventilation. In: J.C. Sinclair M.B. Bracken (Eds.) Effective Care of the Newborn Infant 1992 Oxford University Press Oxford 200-220
38. Henderson-Smart DJ, Bhuta T, Cools F. Elective high frequency oscillatory ventilation versus conventional ventilation for acute pulmonary dysfunction in preterm infants (Cochrane Review). In The Cochrane Library, Issue 1. Chichester: Wiley; 2004.
39. Bhuta T, Henderson-Smart DJ. Rescue high frequency oscillatory ventilation versus conventional ventilation for pulmonary dysfunction in preterm infants (Cochrane Review). In The Cochrane Library, Issue 1. Chichester: Wiley; 2004.
40. Bhuta T, Clark RH, Henderson-Smart DJ. Rescue high frequency oscillatory ventilation vs conventional ventilation for infants with severe pulmonary dysfunction born at or near term (Cochrane Review). In The Cochrane Library, Issue 1. Chichester: Wiley; 2004.
41. D.G. Sweet H.L. Halliday A risk-benefit assessment of drugs used for neonatal chronic lung disease Drug Safety 22 2000 389-404
42. Lemyre B, Davis PG, de Paoli AG. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for apnea of prematurity (Cochrane Review). In The Cochrane Library, Issue 1. Chichester: Wiley; 2004.
43. Davis PG, Lemyre B, de Paoli AG. Nasal intermittent positive pressure ventilation (NIPPV) versus nasal continuous positive airway pressure (NCPAP) for preterm neonates after extubation (Cochrane Review) In The Cochrane Library, Issue 1. Chichester: Wiley; 2004.
44. D.G. Grier H.L. Halliday Corticosteroids in the prevention and management of bronchopulmonary dysplasia Seminars in Neonatology 8 2003 83-91
45. Yeh TF, Lin YJ, Huang HL. Huang CC et al. Early dexamethasone therapy in preterm infants: A follow-up study Eediatrics. 1998; 101: e7.
46. T.M. O'Shea J.M. Kothadia K.L. Klinepeter et al. Randomized placebo-controlled trial of a 42-day tapering course of dexamethasone to reduce the duration of ventilator dependency in very low birth weight infants: Outcome of study participants at 1-year adjusted age Pediatrics 104 1999 15-21
47. E.S. Shinwell M. Karplus D. Reich et al. Early postnatal dexamethasone treatment and increased incidence of cerebral palsy Archives of Disease in Childhood Fetal and Neonatal Edition 83 2000 F177-F181
48. Halliday HL, Ehrenkranz RA, Doyle LW. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants (Cochrane Review). In The Cochrane Library, Issue 1. Wiley: Chichester; 2004.
49. Halliday HL, Ehrenkranz RA, Doyle LW. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants (Cochrane Review). In The Cochrane Library, Issue 1. Chichester: Wiley; 2004.
50. J.C. Sinclair Weighing risks and benefits in treating the individual patient Clinics in Perinatology 30 2003 251-268
51. S. Oddie N.D. Embleton Risk factors for early onset neonatal group B streptococcal sepsis: Case-control study British Medical Journal 325 2002 308
52. P.T. Heath G. Balfour A.M. Weisner et al. Group B streptococcal disease in UK and Irish infants younger than 90 days Lancet 363 2004 292-294
53. Smaill F. Intrapartum antibiotics for group B streptococcal colonisation (Cochrane Review). In The Cochrane Library, Issue 1. Chichester: Wiley; 2004.
54. Royal College of Obstetricians and Gynaecologists. Prevention of Early Onset Neonatal Group B Streptococcal Disease. RCOG Guideline number 36. London: RCOG, 2003.
55. W.E. Benitz J.B. Gould M.L. Druzin Antimicrobial prevention of early-onset group B streptococcal sepsis: Estimates of risk reduction based on a critical literature review Pediatrics 103 1999 e78
56. A.M. Watkins C.R. West R.W. Cooke Blood pressure and cerebral haemorrhage and ischaemia in very low birthweight infants Early Human Development 19 1989 103-110
57. D.J. Murphy P.L. Hope A. Johnson Neonatal risk factors for cerebral palsy in very preterm babies: Case-control study British Medical Journal 314 1997 404-408
58. J. Lee V.S. Rajadurai K.W. Tan Blood pressure standards for very low birthweight infants during the first day of life Archives of Disease in Childhood Fetal and Neonatal Edition 81 1999 F168-F170
59. Osborn DA, Evans N. Early volume expansion versus inotrope for prevention of morbidity and mortality in very preterm infants (Cochrane Review). In The Cochrane Library, Issue 1. Chichester: Wiley; 2004.
60. Subhedar NV, Shaw NJ. Dopamine versus dobutamine for hypotensive preterm infants (Cochrane Review). In The Cochrane Library, Issue 1. Chichester: Wiley; 2004.
61. Paradissis M, Osborn DA. Adrenaline for prevention of morbidity and mortality in preterm infants with cardiovascular compromise (Cochrane Review). In The Cochrane Library, Issue 1. Chichester: Wiley; 2004.
62. J. Zhang D.J. Penny N.S. Kim Mechanisms of blood pressure increase induced by dopamine in hypotensive preterm neonates Archives of Disease in Childhood Fetal and Neonatal Edition 81 1999 F99-F104
63. M.B. Mizoguchi T.G. Chu F.M. Murphy et al. Dopamine use is an indicator for the development of threshold retinopathy of prematurity British Journal of Ophthalmology 83 1999 425-428
64. I. Al-Aweel D.M. Pursley L.P. Rubin et al. Variations in prevalence of hypotension, hypertension, and vasopressor use in NICUs Journal of Perinatology 21 2001 272-278
65. S.R. Jadcherla Gastroesophageal reflux in the neonate Clinics in Perinatology 29 2002 135-158
66. T.I. Omari C.P. Barnett M.A. Benninga et al. Mechanisms of gastro-oesophageal reflux in preterm and term infants with reflux disease Gut 51 2002 475-479
67. D.J. Mitchell B.G. McClure T.R. Tubman Simultaneous monitoring of gastric and oesophageal pH reveals limitations of conventional oesophageal pH monitoring of milk fed infants Archives of Disease in Childhood 84 2001 273-276
68. L. Grant D. Cochran Can pH monitoring reliably detect gastro-oesophageal reflux in preterm infants? Archives of Disease in Childhood Fetal and Neonatal Edition 85 2001 F155-F157
69. C.S. Peter N. Sprodowski B. Bohnhorst et al. Gastroesophageal reflux and apnea of prematurity: No temporal relationship Pediatrics 109 2002 8-11
70. R.J. Martin Neonatal apnea, bradycardia, and desaturation: pathophysiology, management, and outcome Biology of the Neonate 82 2002 282-284
71. A.E. Carroll M.M. Garrison D.A. Christakis A systematic review of nonpharmacological and nonsurgical therapies for gastroesophageal reflux in infants Archives in Pediatrics and Adolescent Medicine 156 2002 109-113
72. D.J. Henderson-Smart D. Osborn N. Evans et al. Do we practice evidence-based care in our neonatal intensive care units? Clinics in Perinatology 30 2003 333-342
73. A. Ohlsson Knowledge translation and evidence-based perinatal/neonatal health care Neonatal Network 21 2002 69-74
74. I. Chalmers Well informed uncertainties about the effects of treatments British Medical Journal 328 2004 475-476
75. B. Schmidt P. Gillie C. Caco et al. Do sick newborn infants benefit from participation in a randomised trial? Journal of Pediatrics 134 1999 130-131
76. P. Allmark S. Mason A.B. Gill et al. Is it in a neonate's best interest to enter a randomised controlled trial? Journal of Medical Ethics 27 2001 110-113